-
公开(公告)号:US12226548B2
公开(公告)日:2025-02-18
申请号:US18172517
申请日:2023-02-22
Applicant: ORTHOCELL LIMITED
Inventor: Ming Hao Zheng
Abstract: The present invention relates to a method of producing a collagen membrane that has particular mechanical properties. In particular, the present invention relates to a method A of producing a collagen membrane comprising the steps of (i) isolating a collagen-containing tissue and incubating same in an ethanol solution; (ii) incubating the collagen-containing tissue from step (i) in a first solution comprising an inorganic salt and an anionic surfactant in order to denature non-collagenous proteins contained therein; (iii) incubating the collagen-containing tissue produced in step (ii) in a second solution comprising an inorganic acid until the collagen in said material is denatured; and (iv) incubating the collagen-containing tissue produced in step (iii) in a third solution comprising an inorganic acid with simultaneous mechanical stimulation for sufficient time to enable the collagen bundles in said collagen-containing tissue to align; wherein the mechanical stimulation comprises applying tension cyclically to the collagen-containing tissue.
-
公开(公告)号:US20250019418A1
公开(公告)日:2025-01-16
申请号:US18708744
申请日:2022-09-09
Inventor: Andre PALMER , Pedro J. CABRALES AREVALO , Xiangming GU
IPC: C07K14/805 , A61K38/00 , C07K1/113 , C07K1/36
Abstract: Disclosed are methods for producing methemoglobin or polymerized methemoglobin. Also provided are pharmaceutical compositions comprising methemoglobin complexed with haptoglobin or polymerized methemoglobin, as well as methods of using thereof to treat cyanide and hydrogen sulfide poisoning.
-
公开(公告)号:US20240391963A1
公开(公告)日:2024-11-28
申请号:US18693641
申请日:2022-09-23
Applicant: THE UAB RESEARCH FOUNDATION
Inventor: Michael Niederweis , Mikhail Pavlenok
IPC: C07K14/35 , C07K1/113 , C12P21/02 , C12R1/19 , G01N33/487
Abstract: A preparing a purified population of single chain Mycobacterium smegmatis porins.
-
公开(公告)号:US20240368240A1
公开(公告)日:2024-11-07
申请号:US18751768
申请日:2024-06-24
Applicant: Eli Lilly and Company
Inventor: Stephanie Ruth COFFIN , Michael Oliver FREDERICK , Ankur JALAN , Neil John KALLMAN , Michael Eugene KOPACH , Kevin Dale SEIBERT , Sergey Vladimirovich TSUKANOV
IPC: C07K14/645 , C07C233/47 , C07C271/22 , C07K1/113 , C07K14/00 , C07K14/605
Abstract: The present invention provides novel intermediates and processes useful in the manufacture of tirzepatide, or a pharmaceutically acceptable salt thereof.
-
公开(公告)号:US20240309064A1
公开(公告)日:2024-09-19
申请号:US18637124
申请日:2024-04-16
Applicant: Regeneron Pharmaceuticals, Inc.
Inventor: Shunhai Wang , Ning Li , Hunter Chen , Amardeep Singh Bhupender Bhalla , Shawn M. Lawrence , Amy S. Johnson , Meghan Casey , Jaimie Grapel
IPC: C07K14/71 , A61K38/18 , C07K1/113 , C07K1/16 , C07K1/18 , C07K1/22 , C07K1/36 , C07K16/22 , C07K16/28 , C12N5/00 , C12N15/66 , C12P21/02 , C12P21/06 , G01N30/02 , G01N30/80
CPC classification number: C07K14/71 , A61K38/1866 , C07K1/113 , C07K1/16 , C07K1/18 , C07K1/22 , C07K1/36 , C07K16/22 , C07K16/283 , C12N5/0018 , C12N5/0031 , C12N15/66 , C12P21/02 , C12P21/06 , G01N30/80 , C07K2317/622 , C07K2319/30 , C07K2319/33 , C12N2800/10 , G01N2030/027
Abstract: The present disclosure pertains to compositions comprising anti-VEGF proteins and methods for producing such compositions.
-
公开(公告)号:US20240294606A1
公开(公告)日:2024-09-05
申请号:US18638362
申请日:2024-04-17
Applicant: Regeneron Pharmaceuticals, Inc.
Inventor: Shunhai Wang , Ning Li , Hunter Chen , Amardeep Singh Bhupender Bhalla , Shawn M. Lawrence , Amy Johnson , Meghan Casey , Jaimie Grapel
IPC: C07K14/71 , A61K38/18 , C07K1/113 , C07K1/16 , C07K1/18 , C07K1/22 , C07K1/36 , C07K16/22 , C07K16/28 , C12N5/00 , C12N15/66 , C12P21/02 , C12P21/06 , G01N30/02 , G01N30/80
CPC classification number: C07K14/71 , A61K38/1866 , C07K1/113 , C07K1/16 , C07K1/18 , C07K1/22 , C07K1/36 , C07K16/22 , C07K16/283 , C12N5/0018 , C12N5/0031 , C12N15/66 , C12P21/02 , C12P21/06 , G01N30/80 , C07K2317/622 , C07K2319/30 , C07K2319/33 , C12N2800/10 , G01N2030/027
Abstract: The present disclosure pertains to compositions comprising anti-VEGF proteins and methods for producing such compositions.
-
公开(公告)号:US12054533B2
公开(公告)日:2024-08-06
申请号:US17858629
申请日:2022-07-06
Applicant: Regeneron Pharmaceuticals, Inc.
Inventor: Andrew Tustian , Ankit Vartak , Thomas Daly , Erica Pyles , Nisha Palackal , Shunhai Wang , Ning Li
IPC: C07K1/36 , A61K38/18 , C07K1/113 , C07K1/16 , C07K1/18 , C07K1/22 , C07K14/71 , C07K16/22 , C07K16/28 , C12N5/00 , C12N15/66 , C12P21/02 , C12P21/06 , G01N30/80 , G01N30/02
CPC classification number: C07K14/71 , A61K38/1866 , C07K1/113 , C07K1/16 , C07K1/18 , C07K1/22 , C07K1/36 , C07K16/22 , C07K16/283 , C12N5/0018 , C12N5/0031 , C12N15/66 , C12P21/02 , C12P21/06 , G01N30/80 , C07K2317/622 , C07K2319/30 , C07K2319/33 , C12N2800/10 , G01N2030/027
Abstract: The present disclosure pertains to methods for producing aflibercept from a host cell cultured in a chemically defined medium (CDM) including purification of aflibercept, wherein aflibercept following purification includes aflibercept variants that have at least one oxidized amino acid residue selected from the group consisting of tryptophan, histidine and a combination thereof.
-
公开(公告)号:US20240228531A9
公开(公告)日:2024-07-11
申请号:US18278519
申请日:2022-02-22
Applicant: PreOmics GmbH
Inventor: Nils A. Kulak , Sebastian H. Johansson , Katrin Hartinger
CPC classification number: C07K1/30 , C07K1/1136
Abstract: The present invention relates to a method of processing or fractionating a sample comprising proteins, polypeptides and/or peptides, said method comprising (a) changing the physicochemical conditions of said sample; and (b) performing one or both of the following (i) and (ii): (i) adding solid particulate matter to said sample; and (ii) performing said method in a vessel with a rough surface; wherein steps (a) and (b) can be effected concomitantly or in any order; and wherein said processing or fractionating yields one or more first fractions of proteins, polypeptides and/or peptides as a precipitate on said particulate matter and/or said inhomogeneous surface, and a second fraction of proteins, polypeptides and/or peptides remaining in a supernatant.
-
公开(公告)号:US20240166689A1
公开(公告)日:2024-05-23
申请号:US18460300
申请日:2023-09-01
Applicant: Chugai Seiyaku Kabushiki Kaisha
Inventor: Shiori KARIYUKI , Takeo IIDA , Miki KOJIMA , Ryuichi TAKEYAMA , Mikimasa TANADA , Tetsuo KOJIMA , Hitoshi IIKURA , Atsushi MATSUO , Takuya SHIRAISHI , Takashi EMURA , Kazuhiko NAKANO , Koji TAKANO , Kousuke ASOU , Takuya TORIZAWA , Ryusuke TAKANO , Nozomi HISADA , Naoaki MURAO , Atsushi OHTA , Kaori KIMURA , Yusuke YAMAGISHI , Tatsuya KATO
IPC: C07K7/64 , C07H21/04 , C07K1/113 , C07K5/087 , C07K5/103 , C07K7/06 , C07K7/08 , C07K11/00 , C07K11/02 , C07K19/00 , C12P21/02
CPC classification number: C07K7/64 , C07H21/04 , C07K1/113 , C07K5/0812 , C07K5/1013 , C07K7/06 , C07K7/08 , C07K11/00 , C07K11/02 , C07K19/00 , C12P21/02 , A61K38/00
Abstract: An object of the present invention is to provide methods of discovering drugs effective for tough targets, which have conventionally been discovered only with difficulty. The present invention relates to novel methods for cyclizing peptide compounds, and novel peptide compounds and libraries comprising the same, to achieve the above object.
-
公开(公告)号:US20240156976A1
公开(公告)日:2024-05-16
申请号:US18352362
申请日:2023-07-14
Applicant: ImmunoGen, Inc.
Inventor: Xinfang LI , Jared M. WORFUL
CPC classification number: A61K47/6803 , A61K47/6809 , A61K47/6819 , A61K47/6849 , A61K47/6867 , C07K1/113 , C07K16/2896 , C07K16/32
Abstract: The invention provides a one-step process for preparing a cell-binding agent cytotoxic agent conjugate comprising contacting a cell-binding agent with a cytotoxic agent to form a first mixture comprising the cell-binding agent and the cytotoxic agent and contacting the first mixture comprising the cell-binding agent and the cytotoxic agent with a bifunctional crosslinking reagent, which provides a linker, in a solution having a pH of about 4 to about 9 to provide a second mixture comprising the cell-binding agent cytotoxic agent conjugate, wherein the cell-binding agent is chemically coupled through the linker to the cytotoxic agent, free cytotoxic agent, and reaction by-products. The second mixture is then optionally subjected to purification to provide a purified cell-binding agent cytotoxic agent conjugate.
-
-
-
-
-
-
-
-
-